Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118834144 | 11883414 | 4 | F | 201503 | 20160823 | 20151231 | 20160907 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2015VAL001550 | VALIDUS | 0.00 | Y | 0.00000 | 20160907 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118834144 | 11883414 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | 50 MG, BID | U | 17963 | 50 | MG | |||||||
| 118834144 | 11883414 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, QMO | U | 0 | 60 | MG | |||||||
| 118834144 | 11883414 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 100 ?G, ONCE/SINGLE (TEST DOSE) | 100 | UG | 0 | 100 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118834144 | 11883414 | 1 | Product used for unknown indication |
| 118834144 | 11883414 | 2 | Neuroendocrine carcinoma |
| 118834144 | 11883414 | 3 | Neuroendocrine carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118834144 | 11883414 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118834144 | 11883414 | Blood pressure increased | |
| 118834144 | 11883414 | Blood pressure systolic increased | |
| 118834144 | 11883414 | Chest discomfort | |
| 118834144 | 11883414 | Decreased appetite | |
| 118834144 | 11883414 | Diarrhoea | |
| 118834144 | 11883414 | Energy increased | |
| 118834144 | 11883414 | Fatigue | |
| 118834144 | 11883414 | Heart rate irregular | |
| 118834144 | 11883414 | Hypertension | |
| 118834144 | 11883414 | Injection site mass | |
| 118834144 | 11883414 | Palpitations | |
| 118834144 | 11883414 | Somnolence | |
| 118834144 | 11883414 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118834144 | 11883414 | 2 | 20140827 | 0 | ||
| 118834144 | 11883414 | 3 | 20140818 | 20140818 | 0 |